Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any specific granule deficiency in which the cause of the disease is a mutation in the CEBPE gene.
Features include always present findings: Impaired neutrophil bactericidal activity, Hyposegmentation of neutrophil nuclei, Absent neutrophil specific granules, and Low neutrophil alkaline phosphatase and others. 13 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 11 | Absent neutrophil lactoferrin, Neutrophil nuclear clefts, Impaired neutrophil bactericidal activity |
CEBPE encodes CCAAT enhancer binding protein epsilon (281 aa). Transcriptional activator. C/EBP are DNA-binding proteins that recognize two different motifs: the CCAAT homology common to many promoters and the enhanced core homology common to many enhancers. Highest expression in Whole Blood (11.1 TPM) and Spleen (3.1 TPM).
Specific granule deficiency 1 is associated with mutations in the CEBPE gene on chromosome 14.
The CEBPE protein participates in CEBPE gene:RXRA:RARA:atRA, CEBPE gene:RARA:RXRA, and CEBPE gene:EP300:SPI1:PML pathways.
CEBPE is classified as a druggable target (Transcription Factor category) with score 0.0.
Genetic testing for CEBPE is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 8 always present features.
No clinical trials have been registered for specific granule deficiency 1.
4 publications have been identified in PubMed for specific granule deficiency 1. Research spans Basic Science / Preclinical (75%) and Other (25%).
Xu J (2025). [PMID: 40347515](https://pubmed.ncbi.nlm.nih.gov/40347515/). *Adv Sci (Weinh)*. [Basic Science / Preclinical]
Tamaru T (2025). [PMID: 40581342](https://pubmed.ncbi.nlm.nih.gov/40581342/). *Clin Exp Immunol*. [Basic Science / Preclinical]
Dwivedi P (2025). [PMID: 41026272](https://pubmed.ncbi.nlm.nih.gov/41026272/). *J Clin Immunol*. [Other]
Brouwer MAE (2025). [PMID: 41321749](https://pubmed.ncbi.nlm.nih.gov/41321749/). *EJHaem*. [Basic Science / Preclinical]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 11:55 PM UTC
Online Mendelian Inheritance in Man
Head and neck | 1 | Neutrophil nuclear clefts |
Ears | 1 | Recurrent otitis media |
Lungs and breathing | 1 | Recurrent pneumonia |